F040 Slovenia (Part 1): What to learn from Slovenia about drug regulation?
This episode is the first part of a two-part series about healthcare in Slovenia. Given that drug prices are a consistently controversial topic in the US healthcare system, the first part of the series explains European regulation. Why are drug prices in Europe more affordable? How does drug pricing and medication management work in Europe and Slovenia? Why is it hard to imagine that an opioid crisis or widespread use of ADHD drugs would happen in this part of Europe? The speaker explaining the topics is the Head of the medication management department at the Healthcare Insurance Institute of Slovenia Jurij Fürst.
